Pfizer Products India Private Limited - Company Profile

It is a business services foreign private limited company based in Mumbai, Maharashtra, India, established in 1996.
1996 Mumbai, Maharashtra, India Active
Last Updated:
About Pfizer Products India Private Limited

Pfizer Products India Private Limited, a active foreign private limited company, was established on 19 December 1996 in Mumbai, Maharashtra, India. Engaging in business support services within the trade sector, it holds CIN: U24230MH1996FTC148003. Registered under ROC Roc Mumbai I. it is unlisted. It has an authorized capital of ₹17.50 Cr and a paid-up capital of ₹17.50 Cr.

Formerly known as Pharmacia India Private Limited. It upholds a compliant status. Employing 279 professional, Its leadership includes Darshak Pradip Bhagat (Director), Seema Shantharam Pai (Whole-Time Director), Shabbar Abid Vhora (Whole-Time Director). Past directors included Rajinder Kumar Kaul, Dipali Talwar, Gul Raj Bhatia. It holds ₹1.11 Cr open charges and no settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at The Capital, 1802 / 1901, Plot No. C-70, G Block, Bandra Kurla Complex, Bandra (East),, Mumbai, Maharashtra, 400051.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24230MH1996FTC148003

  • Registration Number

    148003

  • Incorporation Date

    19 December 1996

  • Authorized Capital

    ₹17.50 Cr

  • Paid-Up Capital

    ₹17.50 Cr

  • ROC Code

    Roc Mumbai I

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 17.50 Cr
  • Paid Up Capital ₹ 17.50 Cr
  • Company Age 29 Year, 2 Months
  • Last Filing with ROC 31 Mar 2025
  • Open Charges ₹ 1.11 Cr
  • Revenue Growth **** 36.59%
  • Profit Growth **** 116.93%
  • Ebitda **** 71.05%
  • Net Worth 19.17%
  • Total Assets -11.46%
Company report

Pfizer Products India Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Pfizer Products India Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Pfizer Products India Private Limited?
Current Directors
Name Designation Appointment Date Status
Darshak Pradip Bhagat Director 31 Mar 2021 Current
Seema Shantharam Pai Whole-Time Director 25 Sep 2020 Current
Shabbar Abid Vhora Whole-Time Director 29 Sep 2021 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Additional Director 16 Aug 2017 Past
Pramod Abcsdd Director 14 Sep 2012 Past
Pramod Abcsdd Whole-Time Director 30 Apr 2017 Past
Pramod Abcsdd Director 29 Dec 2006 Past
Pramod Abcsdd Additional Director 29 Sep 2008 Past
Pramod Abcsdd Additional Director 29 Sep 2021 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Pfizer Products India.

Pfizer Products India Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 36.59% increase. The company also saw a substantial improvement in profitability, with a 116.93% increase in profit. The company's net worth Soared by an impressive increase of 19.17%.

Pfizer Products India revenue growth over time
Pfizer Products India profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
36.59%
*******
*******
*******
*******
Revenue from Operations
*******
33.42%
*******
*******
*******
*******
Total Assets
*******
-11.46%
*******
*******
*******
*******
Profit or Loss
*******
116.93%
*******
*******
*******
*******
Net Worth
*******
19.17%
*******
*******
*******
*******
EBITDA
*******
71.05%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Pfizer Products India?

In 2023, Pfizer Products India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹11,102,000.00

Satisfied Charges

₹0

Charges Breakdown by Lending Institutions
  • Corproation Bank : 1.11 Cr
Latest Charge Details
Date Lender Amount Status
04 Jun 2002 Corproation Bank ₹0.35 M Open
17 May 2002 Corproation Bank ₹0.35 M Open
28 Aug 2001 Corproation Bank ₹6.00 M Open
25 Jun 2001 Corproation Bank ₹0.25 M Open
19 Jun 2001 Corproation Bank ₹0.62 M Open

Explore comprehensive loan charge details -

How Many Employees Work at Pfizer Products India?

Pfizer Products India has a workforce of 279 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Pfizer Products India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Pfizer Products India's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Pfizer Products India
Recent Activity within the Organization
  • Director Appointment

    Pratik Umesh Shah was appointed as a Company Secretary was appointed as a Company Secretary on 24 Jan 2026 & has been associated with this company since 1 month 10 days . was recorded as a recent event.

  • Annual General Meeting

    Progress on Pfizer Products India Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was documented.

  • Balance Sheet

    Progress on Pfizer Products India Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai I. was documented.

  • Director Appointment

    The activity Shabbar Abid Vhora was appointed as a Whole-time director was appointed as a Whole-time director on 29 Sep 2021 & has been associated with this company since 4 years 5 months . was completed.

  • Director Appointment

    Darshak Pradip Bhagat was appointed as a Director was appointed as a Director on 31 Mar 2021 & has been associated with this company since 4 years 11 months . was recorded as a recent event.

  • Director Appointment

    The activity Seema Shantharam Pai was appointed as a Whole-time director was appointed as a Whole-time director on 25 Sep 2020 & has been associated with this company since 5 years 5 months . was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Pfizer Products India Private Limited?

The CIN of Pfizer Products India Private Limited is U24230MH1996FTC148003.

Where is Pfizer Products India Private Limited headquartered?

Pfizer Products India Private Limited is headquartered at The Capital, 1802 / 1901, Plot No. C-70, G Block, Bandra Kurla Complex, Bandra (East),, Mumbai, Maharashtra, 400051.

When was Pfizer Products India Private Limited incorporated?

Pfizer Products India Private Limited was incorporated on 19 December 1996.

Who are the current directors of Pfizer Products India Private Limited?

The current directors of Pfizer Products India Private Limited are

What is the primary industry of Pfizer Products India Private Limited?

The primary industry of Pfizer Products India Private Limited is Trade.

Is Pfizer Products India Private Limited a listed company?

Pfizer Products India Private Limited is unlisted.

What is the capital structure of Pfizer Products India Private Limited?

The authorized capital of Pfizer Products India Private Limited is ₹17.50 Cr, and the paid-up capital is ₹17.50 Cr.

What is the compliance status of Pfizer Products India Private Limited?

The compliance status of Pfizer Products India Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available